*A responder was defined as a subject having an improvement in their gastrointestinal well-being, i.e. answering ‘improved’ on a 3-point Likert scale on at least 2 weeks out of the 4 week double-blind period of product consumption
** GI wellbeing was assessed by using a a 3-point Likert scale (improved, no change, worsened) on a weekly basis. Each participant was classified as responder or as a non-responder to assess the magnitude of the effect. A responder was defined as a subject having an improvement in their gastrointestinal well-being, i.e. answering ‘improved’ on the three-point Likert scale, on at least 2 weeks over the 4-week double-blind period of product consumption.
Frequency of digestive symptoms was measured using a 5-point Likert scale that ranged from 0 (never) to 4 (every day of the week). The composite score for these 4 symptoms ranged from 0 (none of the symptoms) to 16 (all symptoms, every day).
Bowel function: Participants were also asked to report daily bowel movements according to the Bristol stool scale.
Health-related quality of life: The Health-related quality of life (HRQoL) was assessed by self-administration of two questionnaires: the Food and Benefits Assessment (FBA) and the Psychological General Well-Being Index (PGWBI) at three time points: baseline, after 4 weeks, and after 8weeks